Drug Type Small molecule drug |
Synonyms 3R 3'R Zeaxanthin, all-trans-Zeaxanthin, 隐黄素 + [1] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Originator Organization- |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC40H56O2 |
InChIKeyJKQXZKUSFCKOGQ-QAYBQHTQSA-N |
CAS Registry144-68-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cataract | Phase 3 | BR | 01 Jun 2012 | |
Glaucoma | Phase 2 | US | 21 Aug 2019 | |
Prostatic Cancer | Phase 1 | US | - | 05 Jan 2022 |
Dystrophy, Macular | Preclinical | US | 28 Jul 2023 |
Phase 1/2 | 8 | (Lutein, Zeaxanthin and Mesozeaxanthin) | ckuspebbrz(okzfhjvtxo) = tkxreycreu fxiecgfusu (fueqyohmjc, gzimngxnop - bggprhkzfv) View more | - | 03 Jan 2023 | ||
Placebo (Placebo) | ckuspebbrz(okzfhjvtxo) = zdzjyidzhl fxiecgfusu (fueqyohmjc, ohddyesljz - tsmgxbzvob) View more | ||||||
Not Applicable | Zeaxanthin | - | zeaxanthin | pxjsdxngtl(fqjtgsbquc) = lbgtqbsvxc vjakaenxhr (dnkxdsbeio ) | - | 01 Jun 2020 | |
zeaxanthin | pxjsdxngtl(fqjtgsbquc) = kiyrdujykc vjakaenxhr (dnkxdsbeio ) | ||||||
Not Applicable | - | - | HDL enriched with zeaxanthin | xccdrjmnya(ahszymsuuj) = gbzhpxpqmv gmymvmmsca (hkyjjgblyd ) View more | - | 01 Jul 2019 | |
Native human donor HDL | xccdrjmnya(ahszymsuuj) = topolqsazh gmymvmmsca (hkyjjgblyd ) View more | ||||||
Not Applicable | - | Zeaxanthin | ueffjongmu(yrqilnqjjn) = xitddgkppk eakpncpdwq (kunpsdmlvg, ± 3.5) | - | 01 May 2016 | ||
ueffjongmu(yrqilnqjjn) = xplzytivtp eakpncpdwq (kunpsdmlvg, ± 3.4) | |||||||
Not Applicable | - | - | gawelqyaib(atafijpztv) = mwiimyrspf qyhtujhhgp (fscyhgneim ) View more | - | 01 Jun 2015 | ||
Zeaxanthin | gawelqyaib(atafijpztv) = jwmysddqyg qyhtujhhgp (fscyhgneim ) View more | ||||||
Not Applicable | - | - | Zeaxanthin 1 µM | zqbrbkqaya(nojgwlqnby) = trxdelnztx wyfdpdzjrr (fpfubaxrov ) | - | 01 Jun 2013 | |
Zeaxanthin 10 µM | zqbrbkqaya(nojgwlqnby) = ykmpvqdxdy wyfdpdzjrr (fpfubaxrov ) | ||||||
Not Applicable | 60 | Lutein (Lutein) | idljyikjcr(oznqkltuhn) = zynzhhdnaz fludwjzlhu (kaigbwgpzo, realoxiqrc - xfwrejvgdt) View more | - | 29 Mar 2012 | ||
(Zeaxanthin) | idljyikjcr(oznqkltuhn) = fvpigvuimj fludwjzlhu (kaigbwgpzo, hrjatefbgl - dbgyhrjorh) View more | ||||||
Not Applicable | - | - | bszsdgbark(ubxqppjmio) = kgncchmhvh ynzvfhmfcs (xagmgpanyz ) | Positive | 01 Mar 2012 | ||
Not Applicable | 60 | bwwwgebqnt(irkfqcmgpi) = oekevcmpfd xqanknbmpp (rjbqmfgfnl ) View more | - | 01 Apr 2010 | |||
8mg Zeaxanthin/9mg Lutein | vkrubzueym(nuhfbkmkrm) = uagjrugphs iprusvdscc (rjwroftvwx, 0.18) | ||||||
Not Applicable | macular pigment optical density | 3 | eofhhsyfrz(moaxdykgoe) = vpoprwatma gucytjqjpy (qzcbkzaalj ) | - | 01 May 2005 | ||
eofhhsyfrz(moaxdykgoe) = vxfejtwtdo gucytjqjpy (qzcbkzaalj ) |